InvestorsHub Logo
Followers 25
Posts 4552
Boards Moderated 0
Alias Born 03/19/2018

Re: None

Thursday, 06/17/2021 1:34:20 PM

Thursday, June 17, 2021 1:34:20 PM

Post# of 111071

ImmCelz - a subsidiary of Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company committed to improving patient lives in the areas of Immunology, Urology, Neurology and Orthopedics.
Creative Medical Technology Holdings, Inc. (CELZ) is focused on regenerative medical solutions for unmet Immunological, Urological, Neurological and Orthopedic needs. We have developed an extensive intellectual property portfolio utilizing stem cells and interrelated technologies for the treatment of multiple indications and commercialized complete patented and trademarked protocols for erectile dysfunction under the CaverStem® brand and the FemCelz® brand for the treatment of female sexual dysfunction. Our StemSpine® technology has undergone a pilot study and is prepared for commercialization of it’s autologous (patients own stem cells) program with the vision of progressing it’s patented allogenic (donor cells) program through FDA clinical trial. CELZ is also breaking new ground with its ImmCelz® technology for the treatment of multiple indications. Our team consists of leading physicians and scientists specializing in regenerative medicine. Our “science-first” approach to procedures ensures that all of our technology is proven to be both safe and effective.


Presenter: Dr. Thomas Ichim A real PHD!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News